Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes-Reference-Cited by-同舟云学术

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes

Published:2015-06 Issue:6 Volume:22 Page:607-615
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:

Author:

Caan Bette,LaCroix Andrea Z.,Joffe Hadine,Guthrie Katherine A.,Larson Joseph C.,Carpenter Janet S.,Cohen Lee S.,Freeman Ellen W.,Manson JoAnn E.,Newton Katherine,Reed Susan,Rexrode Kathy,Shifren Jan,Sternfeld Barbara,Ensrud Kris

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference25 articles.

1. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.;Williams;Climacteric,2008

2. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life.;Williams;Maturitas,2009

3. Healthcare seeking and treatment for menopausal symptoms in the United States.;Williams;Maturitas,2007

4. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.;Joffe;JAMA Intern Med,2014

5. Methods for the design of vasomotor symptom trials: the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health Network.;Newton;Menopause,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autonomic nervous system dysfunction throughout menopausal transition: A potential mechanism underpinning cardiovascular and cognitive alterations during female ageing;The Journal of Physiology;2023-12-08

2. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer;Drug Research;2023-08-30

3. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update;Menopause;2023-06

4. The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council;Journal of Managed Care & Specialty Pharmacy;2023-06

5. The Current Strategy in Hormonal and Non-Hormonal Therapies in Menopause—A Comprehensive Review;Life;2023-02-26